$VVOS News

Vivos Therapeutics Inc (VVOS) Q1 2026 Earnings Call Highlights: Revenue Surges Amid Strategic Shifts

Vivos Therapeutics, Inc. (VVOS) Q1 2026 Earnings Call Transcript

Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update

Vivos Therapeutics Q1 EPS $(0.52) Misses $(0.45) Estimate, Sales $5.141M Beat $4.225M Estimate

Ascendiant Capital Maintains Buy on Vivos Therapeutics, Lowers Price Target to $3

New to The Street to Broadcast Tonight on Bloomberg at 6:30 PM EST - Show #744 Featuring Virtuix Holdings (NASDAQ:VTIX), Neonc Technologies Holdings (NASDAQ:NTHI), Medicus Pharma (NASDAQ:MDCX), YY Group Holding (NASDAQ:YYGH), and Vivos Therapeutics (NASDAQ:VVOS)

HC Wainwright & Co. Maintains Buy on Vivos Therapeutics, Lowers Price Target to $2.5

Vivos Therapeutics shares are trading lower after the company reported worse-than-expected Q4 financial results.

Vivos Therapeutics shares are trading lower after the company reported worse-than-expected Q4 financial results.

Vivos Therapeutics Inc (VVOS) Q4 2025 Earnings Call Highlights: Revenue Growth Amid Strategic ...

Vivos Therapeutics Reports Full Year 2025 Financial Results

Vivos Therapeutics, Inc. (VVOS) Q4 2025 Earnings Call Transcript

Vivos Therapeutics Q4 EPS $(0.58) Misses $(0.48) Estimate, Sales $3.824M Miss $6.447M Estimate

Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call

Vivos Therapeutics, Inc. Q4 2025 Earnings Call Summary

New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings (NASDAQ:VTIX), Medicus Pharma (NASDAQ:MDCX), YY Group Holdings (NASDAQ:YYGH), Vivos Therapeutics (NASDAQ:VVOS), and Stardust Power (NASDAQ:SDST)

New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX)

Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners

Why Did Vivos Therapeutics (VVOS) Stock Jump Over 21% After Hours

Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market